Sartorius Aktiengesellschaft (ETR:SRT) Stock Price Down 4.4% - Time to Sell?

Key Points

• Sartorius Aktiengesellschaft's stock price dropped by 4.4% during mid-day trading on Wednesday, closing at €160.00 ($186.05) after hitting a low of €159.40 ($185.35).
• The company has a market capitalization of $12.57 billion and a P/E ratio of 81.39, reflecting its valuation in the bioprocess solutions and lab products industry.
• Sartorius Aktiengesellschaft is known for providing a wide range of bioprocess solutions and lab products, including various types of bioreactors and fluid management products.

Sartorius Aktiengesellschaft (ETR:SRT - Get Free Report)'s share price fell 4.4% during trading on Wednesday . The stock traded as low as €159.40 ($187.53) and last traded at €160.00 ($188.24). 2,650 shares were traded during mid-day trading, The stock had previously closed at €167.40 ($196.94).

Sartorius Aktiengesellschaft Stock Up 1.3%

The company has a current ratio of 2.02, a quick ratio of 0.36 and a debt-to-equity ratio of 169.56. The business has a 50-day moving average price of €163.92 and a 200-day moving average price of €172.73. The firm has a market cap of $12.28 billion, a P/E ratio of 79.48, a P/E/G ratio of 2.28 and a beta of 0.93.

Sartorius Aktiengesellschaft Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.